STOCK TITAN

Nano Mobile Healthcare (OTCMKTS: VNTH) signs Neptune deal and reshapes leadership

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nano Mobile Healthcare, Inc. reported that on July 29, 2026 its control shareholder, Opportunity Zones Capital LLC, closed the sale of 50,000,000 shares of preferred stock (a control block) to Mr. Cheng Chung Sing under a Securities Purchase Agreement dated March 31, 2026.

The company also entered into a Share Exchange and Acquisition Agreement with Neptune Engineering Limited, under which Neptune is expected to become a 100% wholly owned operating subsidiary. Upon consummation, Nano Mobile Healthcare will acquire all 10,000 ordinary shares of Neptune and Neptune shareholders will receive 20,000,000 post restructuring common shares of Nano Mobile Healthcare. The agreement includes customary representations, warranties and covenants, including regulatory approval efforts and a Neptune shareholder vote. Following execution, the board elected Cheng Chung Sing as director and chairman, Cheng Chung Yu as director and CEO, and Angel Yik as director, secretary and CFO, while Roy Watson continues as president.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Preferred shares control block sold 50,000,000 shares Control shareholder sold preferred stock to Mr. Cheng Chung Sing on July 29, 2026
Neptune ordinary shares to be acquired 10,000 shares All issued and outstanding ordinary shares of Neptune Engineering to be transferred
Nano Mobile common shares to Neptune holders 20,000,000 shares Post restructuring common stock to be issued to Neptune shareholders upon consummation
Merger agreement execution date July 29, 2026 Date Nano Mobile Healthcare entered the Share Exchange and Acquisition Agreement with Neptune
Material Definitive Agreement regulatory
"Item 1.01. Entry Into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
Share Exchange and Acquisition Agreement financial
"entered into a Share Exchange and Acquisition Agreement ("The Merger Agreement")"
wholly owned and operating subsidiary financial
"Neptune will become a 100% wholly owned and operating subsidiary of the Company"
Emerging growth company regulatory
"Emerging growth company [X]"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Encumbrances financial
"Neptune Shares), free and clear of all Encumbrances"
Encumbrances are legal claims, liens, pledges or other restrictions attached to an asset that limit its use, sale or the amount of value that can be obtained from it. For investors they matter because encumbrances reduce an asset’s effective worth and can complicate ownership or financing—like buying a house that still has a mortgage or a lien, which lowers what you can keep or borrow against the property.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What control stock transaction did Nano Mobile Healthcare (VNTH) disclose?

Nano Mobile Healthcare disclosed that Opportunity Zones Capital LLC closed the sale of 50,000,000 preferred shares, a control block, to Mr. Cheng Chung Sing on July 29, 2026 under a Securities Purchase Agreement dated March 31, 2026, shifting control ownership.

What are the key terms of Nano Mobile Healthcare (VNTH) and Neptune Engineering merger?

Nano Mobile Healthcare entered a Share Exchange and Acquisition Agreement with Neptune Engineering under which Neptune is expected to become a 100% wholly owned subsidiary. Nano Mobile will acquire 10,000 ordinary Neptune shares, and Neptune shareholders will receive 20,000,000 common shares of Nano Mobile upon consummation.

How many Nano Mobile Healthcare (VNTH) shares will Neptune shareholders receive?

Upon consummation of the merger, shareholders of Neptune Engineering are to receive 20,000,000 post restructuring shares of Nano Mobile Healthcare common stock in exchange for all 10,000 ordinary shares of Neptune, making Neptune a fully owned operating subsidiary.

What approvals and covenants are included in the Neptune merger for VNTH?

The merger agreement includes customary representations, warranties and covenants, including maintaining business conduct during the interim period, using reasonable best efforts to obtain governmental and regulatory approvals, and convening a Neptune shareholder meeting to approve the agreement and related transactions.

What leadership changes did Nano Mobile Healthcare (VNTH) announce with the Neptune deal?

Following execution of the merger agreement, the board elected Cheng Chung Sing as director and chairman, Cheng Chung Yu as director and CEO, and Angel Yik as director, secretary and CFO, while Roy Watson was approved to continue serving as the company’s president.

Will Neptune Engineering immediately become a subsidiary of Nano Mobile Healthcare (VNTH)?

Neptune Engineering is expected to become a 100% wholly owned operating subsidiary of Nano Mobile Healthcare upon consummation of the merger. Completion remains subject to the agreement’s conditions, including regulatory efforts and approval by Neptune’s shareholders through a convened meeting.
false 0001497130 0001497130 2026-08-03 2026-08-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

 
   
Date of Report (Date of earliest event reported): August 3, 2026
   

NANO MOBILE HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Nevada File Number: 000-55155 98-0659770
(State of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

370 Amapola Ave., Suite 200-A, Torrance, CA 90501
(Address of principal executive offices) (Zip Code)

 

(424) 358-1046
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Emerging growth company   [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      [X]

Securities registered pursuant to Section l 2(b) of the Act:

Title of each class Trading

 

Trading Symbol(s) Name of each exchange on which registered

Common Stock, par value of

$0.00001

VNTH OTCMKTS

 

 

 Item 1.01. Entry Into a Material Definitive Agreement.
             

On July 29, 2026, the Company’s control shareholder Opportunity Zones Capital LLC closed the sale of 50 million shares of the Company’s Preferred stock (control block) to Mr. Cheng Chung Sing, pursuant to a validly executed Securities Purchase Agreement dated March 31, 2026.

Additionally, On July 29, 2026, the Company entered into a Share Exchange and Acquisition Agreement (“The Merger Agreement”) with NEPTUNE ENGINEERING LIMITED, a private company limited by shares incorporated and existing under the laws of the Hong Kong Special Administrative Region of the People’s Republic of China, whose registered office and principal place of business is at Room 306, 3/F., Kwong Kin Trade Centre, No. 5 Kin Fat Street, Tuen Mun, Hong Kong (“Neptune”). The Merger Agreement provides that, upon the terms and subject to the conditions set forth in the agreement, Neptune will become a 100% wholly owned and operating subsidiary of the Company. The Merger Agreement and the consummation of the transactions contemplated thereby, including the Mergers, have been approved by the boards of directors of Neptune.

Pursuant to the Merger Agreement, upon consummation of the Merger, The Company will receive all of the issued and outstanding share capital of Neptune, being 10,000 ordinary shares of Neptune (the “Neptune Shares”), free and clear of all Encumbrances, and the shareholders of Neptune will receive twenty million (20,000,000 (post restructuring)) shares of the Company’s Common Stock.

The Merger Agreement contains customary representations and warranties from both parties, and each has agreed to customary covenants, including, among others, covenants relating to: (1) the conduct of their respective businesses during the interim period between the execution of the Merger Agreement and the consummation of the Company Merger; (2) the use of reasonable best efforts to obtain governmental and regulatory approvals; and (3) obligations to convene a meeting of the shareholders of Neptune to approve the Merger Agreement and the transactions contemplated thereby.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On July 29, 2026, following the execution of the Share Exchange and Acquisition Agreement (“The Merger Agreement”) with NEPTUNE ENGINEERING LIMITED, the board of directors of the Company elected the following individuals to be officers and directors of the Company:

1. Cheng Chung Sing (Byron) as Director, Chairman of the Board;

2. Cheng Chung Yu (Neptune (HK)) as Director and Chief Executive Officer CEO; and

3. Angel Yik as Director and Secretary, as Chief Financial Officer (CFO).

The Company also approved for Mr. Roy Watson to continue in his role and capacity as the Company’s President. 

 

 

 

Item 9.01.             Financial Statements and Exhibits.

 

(d)  
Exhibit No.    Exhibits
10.1   Share Exchange and Acquisition Agreement
10.2   Board Resolution for the resignation, and appointment of Officers

 

 

 

  

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

NANO MOBILE HEALTHCARE, INC

 

Dated:

August 3, 2026

 

By:

 

 

/s/ Roy Watson

    Roy Watson
    President

 

 

Filing Exhibits & Attachments

5 documents